Quantcast
Channel: CFO Moves
Viewing all articles
Browse latest Browse all 281

CFO Moves – week ending October 12, 2018

$
0
0

CFO Moves this week include:

Square, Inc. Starbucks Corporation Hyatt Hotels Corporation
Tupperware Brands Corporation CVS Health 8×8, Inc.
Doctor On Demand Revance Therapeutics, Inc. Pain Therapeutics, Inc.
Manitex International, Inc. Planview Albireo Pharma, Inc.
Noodles & Company Higher Logic Revolution Foods
Dominion Energy Sikich Synergy Medsales
Prevalent, Inc.

Would you like to receive our weekly CFO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.

Should you have any CFO Moves to report, please email us.

NOTE: CFO Search Report available monthly to CFOs only. Read more here.

CFO Moves is published by Samuel Dergel (Executive Search Consultant and CFO & Financial Executive Search Specialist with Dergel Executive Search). Samuel can be reached by email at samuel@dergelcfo.com or by phone at +1 (415) 738-2070.

+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +

Square, Inc. [SAN FRANCISCO] (NYSE: SQ) announced that Sarah Friar has informed the company of her intention to step down as Chief Financial Officer of Square in order to accept an offer to become Chief Executive Officer of Nextdoor. Friar will stay at Square into December to ensure an orderly transition.

Patrick Grismer

Starbucks Corporation [SEATTLE] (NASDAQ: SBUX) announced Patrick Grismer has been appointed executive vice president and chief financial officer (cfo). Grismer succeeds Scott Maw, who will retire on November 30. Maw will remain a senior consultant through March 2019 to ensure a smooth transition, with Grismer joining the company on November 12 and assuming the role of cfo on November 30. Grismer joins Starbucks from his current position as cfo of Hyatt, which he has held since joining the company in March 2016. Prior to Hyatt, Grismer held a variety of leadership positions at Yum! Brands over 14 years, including cfo. Before Yum! Brands, Grismer served in a number of finance and strategy positions at The Walt Disney Company over a ten-year period, including vice president of business planning and development for The Disneyland Resort. Grismer began his career as a management consultant with Price Waterhouse.

Hyatt Hotels Corporation [CHICAGO] (NYSE: H) announced that Patrick Grismer has resigned as chief financial officer, effective November 2, 2018, in order to assume the CFO position at Starbucks Corporation. Upon his departure, Grismer will be succeeded by Joan Bottarini, currently senior vice president of finance for the Americas at Hyatt. Bottarini has been with Hyatt since 1999 and held a number of finance positions over her career, including vice president of hotel finance for Asia Pacific, vice president strategic financial planning and analysis, and director financial communications.

Tupperware Brands Corporation [ORLANDO, Fla.] (NYSE: TUP) announced that Michael S. Poteshman plans to retire from his role as Executive Vice President and Chief Financial Officer (“CFO”). Poteshman will continue in his role until March 1, 2019, following the Company’s fiscal year 2018 financial closing process.

CVS Health [Woonsocket, RI] (NYSE: CVS) announced that following the completion of the transaction, Eva C. Boratto, currently CVS Health’s Executive Vice President – Controller and Chief Accounting Officer, will become Executive Vice President and Chief Financial Officer of CVS Health. Shawn M. Guertin has decided to step away for personal and family reasons but will remain with CVS Health until June 2019 to help the combined company with integration and financial planning strategy. Boratto has an extensive financial background that spans more than 20 years and includes senior positions in both the pharmaceutical manufacturing and PBM industries, along with other health care finance roles. She joined CVS Health in 2010 as Senior Vice President, PBM Finance and most recently has served as CVS Health’s Executive Vice President – Controller and Chief Accounting Officer. Prior to joining CVS Health, Ms. Boratto served in a number of executive positions at Merck & Co., including Vice President, U.S. Market Finance Leader, with responsibility for financial oversight of Merck’s U.S. pharmaceutical market, and Vice President, Investor Relations.

Steven Gatoff

8×8, Inc. [SAN JOSE, Calif.] (NYSE: EGHT) announced the appointment of Steven Gatoff as Chief Financial Officer. Mary Ellen Genovese will remain as Chief Financial Officer through the Company’s Form 10-Q filing for the second quarter of fiscal 2019 and will host 8×8’s second fiscal quarter earnings conference call on October 29, 2018. Steven Gatoff will join 8×8 on October 15, 2018. Prior to 8×8, Gatoff has been Chief Financial Officer at Elementum, PagerDuty, Rapid7 and iPass. Prior to these positions, Gatoff held senior finance roles at United Online, Sterling Commerce, and VeriSign. Earlier in his career, Gatoff was an investment banker at several Wall Street firms including Bear Stearns, Credit Suisse, and Morgan Stanley. Mary Ellen Genovese, who has served as 8×8’s Chief Financial Officer since November 2014, has been appointed as Managing Director of European Operations.

Doctor On Demand [SAN FRANCISCO] hired Jeff McCombs as Chief Financial Officer. Prior to joining Doctor On Demand, Jeff served as the Head of Global Business Operations at Facebook, the Chief Financial Officer at Flipboard, Inc., and most recently OpenTable’s Chief Financial Officer.

Revance Therapeutics, Inc. [NEWARK, Calif.] (NASDAQ: RVNC) announced the appointment of Tobin C. Schilke as chief financial officer, effective November 5th. Schilke joins Revance from Achaogen, Inc., where he was chief financial officer since 2016. Prior to Achaogen, he spent 13 years at Roche/Genentech in a variety of senior finance and operational roles including CFO of Roche Products Limited in the United Kingdom, director of commercial FP&A for Genentech’s BioOncology business, and M&A project manager for a number of successful acquisition, spin-out and business development deals for Roche.

Pain Therapeutics, Inc. [AUSTIN, Texas] (NASDAQ: PTIE) announced that Eric Schoen will join its management team as Chief Financial Officer, effective on or before November 7, 2018. Most recently, he was SVP, Finance & Chief Accounting Officer of Vermillion, Inc. Mr. Schoen also spent nine years with PricewaterhouseCoopers.

Manitex International, Inc. [BRIDGEVIEW, Ill.] (NASDAQ: MNTX) announced that Laura R. Yu has been named Senior Vice President and Chief Financial Officer of Manitex International, Inc. Ms. Yu joined Manitex International in May 2018, as Vice President, Finance and Corporate Controller. Her most recent position prior to Manitex was Director, Corporate Finance at Tenneco. Ms. Yu spent more than ten years at Tenneco, having started as a Senior Financial Analyst there in 1999.  She was also Division Finance Manager and Controller during her seven-year career at Filtran, LLC. Her prior experience also includes five years at Quaker Oats and MS Management.

Todd Sanders

Planview [AUSTIN, Texas] announced the appointment of Todd Sanders as Chief Financial Officer. Sanders joins Planview from Symphony RetailAI, a global Artificial Intelligence-enabled decision platforms and solutions provider, where he served as Executive Vice President and Chief Financial Officer since 2013. Sanders began his financial career at Fujitsu, followed by positions at StoreNext, Retalix (now NCR), and Aldata.

Albireo Pharma, Inc. [BOSTON] (NASDAQ: ALBO) announced the appointment of Simon Harford as Chief Financial Officer. Harford will succeed Tom Shea, who is stepping down from the role. Harford most recently was Chief Financial Officer at Parexel International Corporation. Previously, Harford was SVP Finance, Global Pharmaceuticals at GlaxoSmithKline plc. Overall, Harford’s career spans more than 30 years including numerous senior leadership roles across finance and investor relations at GlaxoSmithKline plc., Avon Products, Inc. and Eli Lilly and Company both in the United States and internationally.

Noodles & Company [BROOMFIELD, Colo.] (NASDAQ: NDLS) announced that Ken Kuick has been named the Company’s Chief Financial Officer, effective November 12, 2018. Most recently, he was Chief Accounting Officer for VICI Properties, a real estate investment trust that was spun out of Caesars Entertainment Corporation. Mr. Kuick also served as Chief Accounting Officer for Caesars Entertainment from 2014 to 2017, and as Vice-President, Assistant Controller beginning in 2011. Prior to that, he served a dual role as Chief Financial Officer for Transamerica Investment Management and Controller for Aegon USA Investment Management under Aegon N.V. He has also held leadership roles at Calamos Asset Management and Alberto-Culver Company.

Higher Logic [WASHINGTON] announced Tricia Benedix has joined the leadership team as new chief financial officer. Previously, Benedix held several executive roles for private equity-backed technology companies, serving as chief financial officer for Social Solutions, Relias Learning, and Mitratech. She also held numerous financial roles for Sunquest Information Systems and Misys Healthcare Systems.

Denise D. Beckles

Revolution Foods [OAKLAND, Calif.] appointed Denise D. Beckles as Chief Financial Officer. Beckles previously served as Chief Strategy Officer of Global Business, Global Head of Financial Planning and Analysis, and Chief Financial Officer at Godiva North America. Her prior experience also includes leading business development at Pernod Ricard USA and financial planning at General Electric Company.

Dominion Energy [RICHMOND, Va.] (NYSE: D) announced that Mark F. McGettrick, executive vice president and chief financial officer, will retire on Jan. 1, 2019, capping a 38-year career at the company. Effective Nov. 1, 2018, McGettrick will step down as chief financial officer. James R. “Jim” Chapman, senior vice president-Mergers & Acquisitions and treasurer, will succeed McGettrick as CFO. Chapman, 49, came to Dominion Energy in 2013 after more than 20 years in investment banking and corporate finance, principally related to the utility and energy sector. Among his roles, he was managing director and head of Asia Pacific Power & Utilities Investment Banking at Barclays plc, as well as holding similar senior roles at Barclays and its predecessor firm, Lehman Brothers in New York and overseas. Chapman assumed his current post in February 2016. Once he becomes the company’s chief financial officer, he is expected to retain his role as treasurer.

Ryan Spohn

Sikich [CHICAGO] hired Ryan Spohn as its chief financial officer. Before joining Sikich, Spohn was the international chief financial officer for InnerWorkings. Spohn also served as InnerWorkings’ interim chief financial officer and senior vice president and corporate controller. Prior to his time at InnerWorkings, Spohn was director of finance for Siemens’ healthcare diagnostics division.

Synergy Medsales [DALLAS] announced the addition of Mike McDonald, previous COO of Thermi Aesthetics, to their dynamic executive team as Chief Financial Officer (CFO).  McDonald joins from previous executive roles from Thermi Aesthetics to PrimCogent and SBMI (Erchonia Zerona).

Prevalent, Inc. [WARREN, N.J.] announced the appointment of James DeBlasio as Chief Financial Officer and Vice President of Operations. Mr. DeBlasio joins Prevalent from technology startup, Kiswe Mobile, where, as an Investor, he held the roles of Chief Financial Officer, Head of Sales, and Head of Strategy. From 2013 to 2016, DeBlasio was the Executive Vice President of Operations for York Telecom Corporation, a Unified Communications Company. Prior to that, Mr. DeBlasio was the President, Chief Executive Officer, and Board Member at Internap Network Services Corporation, a position he held since 2005.


Viewing all articles
Browse latest Browse all 281

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>